| |
|
|
|
|
|
|
|
|
1. |
Record Nr. |
UNINA9910456407003321 |
|
|
Autore |
Goozner Merrill <1950-> |
|
|
Titolo |
The $800 million pill [[electronic resource] ] : the truth behind the cost of new drugs / / Merrill Goozner |
|
|
|
|
|
|
|
Pubbl/distr/stampa |
|
|
Berkeley, : University of California Press, 2004 |
|
|
|
|
|
|
|
ISBN |
|
1-282-35824-3 |
9786612358241 |
0-520-93928-X |
1-59734-450-8 |
|
|
|
|
|
|
|
|
Descrizione fisica |
|
1 online resource (304 p.) |
|
|
|
|
|
|
Disciplina |
|
|
|
|
|
|
Soggetti |
|
Prescription pricing |
Drugs - Prices |
Pharmaceutical industry |
Consumer education |
Electronic books. |
|
|
|
|
|
|
|
|
Lingua di pubblicazione |
|
|
|
|
|
|
Formato |
Materiale a stampa |
|
|
|
|
|
Livello bibliografico |
Monografia |
|
|
|
|
|
Note generali |
|
Description based upon print version of record. |
|
|
|
|
|
|
Nota di bibliografia |
|
Includes bibliographical references and index. |
|
|
|
|
|
|
Nota di contenuto |
|
Front matter -- Contents -- Introduction -- PART ONE. BIOHYPE -- PART TWO. DIRECTED RESEARCH -- PART THREE. BIG PHARMA -- Notes -- Bibliography -- Acknowledgments -- Index |
|
|
|
|
|
|
|
|
Sommario/riassunto |
|
Why do life-saving prescription drugs cost so much? Drug companies insist that prices reflect the millions they invest in research and development. In this gripping exposé, Merrill Goozner contends that American taxpayers are in fact footing the bill twice: once by supporting government-funded research and again by paying astronomically high prices for prescription drugs. Goozner demonstrates that almost all the important new drugs of the past quarter-century actually originated from research at taxpayer-funded universities and at the National Institutes of Health. He reports that once the innovative work is over, the pharmaceutical industry often steps in to reap the profit. Goozner shows how drug innovation is driven by dedicated scientists intent on finding cures for diseases, not by pharmaceutical firms whose bottom line often takes precedence |
|
|
|
|
|
|
|
|
|
|
|
|
|
over the advance of medicine. A university biochemist who spent twenty years searching for a single blood protein that later became the best-selling biotech drug in the world, a government employee who discovered the causes for dozens of crippling genetic disorders, and the Department of Energy-funded research that made the Human Genome Project possible--these engrossing accounts illustrate how medical breakthroughs actually take place. The |
|
|
|
|
|
|
2. |
Record Nr. |
UNINA9910149171503321 |
|
|
Autore |
Tallon Carol |
|
|
Titolo |
Competitive intelligence : the key to strategic advantage : a guide for small business owners / / Carol Tallon |
|
|
|
|
|
|
|
Pubbl/distr/stampa |
|
|
Cork, Ireland : , : NuBooks, , 2011 |
|
©2011 |
|
|
|
|
|
|
|
|
|
ISBN |
|
|
|
|
|
|
Descrizione fisica |
|
1 online resource (42 p.) |
|
|
|
|
|
|
Disciplina |
|
|
|
|
|
|
Soggetti |
|
Business intelligence |
Competition |
|
|
|
|
|
|
|
|
Lingua di pubblicazione |
|
|
|
|
|
|
Formato |
Materiale a stampa |
|
|
|
|
|
Livello bibliografico |
Monografia |
|
|
|
|
|
Note generali |
|
Description based upon print version of record. |
|
|
|
|
|
|
Nota di contenuto |
|
1: INTRODUCTION; 2: COMPETITIVE INTELLIGENCE; 3: COMPETITORS; 4: INFORMATION; 5: COMPETITIVE ADVANTAGE; 6: LEARN WHAT WORKS; 7: MANAGING COMPETITIVE INTELLIGENCE; 8: PROTECTING YOUR OWN INFORMATION; ABOUT THE AUTHOR; ABOUT OAK TREE PRESS |
|
|
|
|
|
|
|
|
Sommario/riassunto |
|
Competitive Intelligence is the process of researching, analysing and, most importantly, using intelligent data from any available information sources with the aim of out-performing competitors through a sustainable competitive advantage. The NuBook is a practical guide for small business owner/managers. |
|
|
|
|
|
|
|
| |